EVOK — Evoke Pharma Share News
0.000.00%
Last trade - 00:00- $18.86m
- $12.28m
- $10.25m
Brief: Evoke Pharma And EVERSANA Extend Commercialization Partnership To Further Support GIMOTI
Brief: Evoke Pharma Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Evoke Pharma Inc reports results for the quarter ended in September - Earnings Summary
Brief: Evoke Pharma Reports Q3 2021 Financial Results
Brief: Evoke Pharma Reports Second Quarter 2021 Financial Results
Evoke Pharma Inc reports results for the quarter ended in June - Earnings Summary
Evoke Pharma Inc expected to post a loss of 8 cents a share - Earnings Preview
Evoke Pharma Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Evoke Pharma And Eversana Announce Positive Findings From Second Gimoti® Market Research Study
U.S. STOCKS ON THE MOVE-Gap, Wendy's, Fastly, Delta Air Lines, crypto stocks
Brief: Evoke Pharma Announces FDA Orange Book Listing Of U.S. Patent For Gimoti
Evoke Pharma: Rises on FDA Orange Book listing of U.S. patent for nasal spray
U.S. STOCKS ON THE MOVE-Evoke Pharma, American Well, Perrigo
Evoke Pharma: Drops as Q1 loss widens on nasal spray costs
Evoke Pharma Inc reports results for the quarter ended in March - Earnings Summary
Brief: Evoke Pharma Reports First Quarter 2021 Financial Results
Evoke Pharma Inc expected to post a loss of 6 cents a share - Earnings Preview
Evoke Pharma: Up on U.S. patent for nasal spray
Brief: Evoke Pharma Receives Notice Of Allowance From U.S. Patent And Trademark Office